MG ‐ K10 in Moderate‐to‐Severe Asthma: Extending the Dosing Interval Without Compromising Efficacy

Clinical and Experimental Allergy · Published 2026-06-23 · DOI 10.1111/cea.70375

Free full text

Authors (2)

Feizhou Zhang, Lanfang Tang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhang, F., Tang, L. (2026). MG ‐ K10 in Moderate‐to‐Severe Asthma: Extending the Dosing Interval Without Compromising Efficacy. Clinical and Experimental Allergy. https://doi.org/10.1111/cea.70375

Related articles

• Probiotic‐Derived CpG ‐ DNA Enhances Food Allergy Immunotherapy via TLR9 ‐Dependent Breg Induction and IL ‐10 Epigenetic Activation · Clinical and Experimental Allergy · 2026 · Same journal
• Prevention and Management of Anaphylaxis: How Are We Doing? · Clinical and Experimental Allergy · 2026 · Same journal
• Food Allergy Incidence Among Hong Kong Children From 2005 to 2024 · Clinical and Experimental Allergy · 2026 · Same journal
• Predictors of Non‐Response to Initial Medical Treatments for Eosinophilic Esophagitis · Clinical and Experimental Allergy · 2026 · Same journal
• Risk of Systemic Reactions After Repeated Large Local Reactions in Hymenoptera Venom Allergy: A Real‐World Study · Clinical and Experimental Allergy · 2026 · Same journal
• Trajectories of Body Mass Index in the First 18 Years of Life and Eczema in Early Adulthood: A Prospective Cohort Study · Clinical and Experimental Allergy · 2026 · Same journal
• Emerging Paediatric Uses of Dupilumab Beyond Approvals · Clinical and Experimental Allergy · 2026 · Same journal
• Allergy in Latin America: Great Need, Even Greater Opportunity · Clinical and Experimental Allergy · 2026 · Same journal
• There Is No Gold Standard in Allergy Diagnosis: Time for Methodologically Correct Terminology · Clinical and Experimental Allergy · 2026 · Same journal
• National and Individual‐Level Economic Burden of Local Corticosteroid Use and Concomitant Use of Multiple Local Corticosteroid Formulations—A Nationwide Cohort Study · Clinical and Experimental Allergy · 2026 · Same journal